Cargando…
Knockdown of NSD2 Suppresses Renal Cell Carcinoma Metastasis by Inhibiting Epithelial-Mesenchymal Transition
Background: Renal cell carcinoma (RCC) accounts for around 85% of all primary kidney neoplasms, which is one of top 10 common cancers worldwide. Nuclear receptor suppressor of variegation, enhancer of zeste, and trithorax (SET) domain-containing 2 (NSD2), belonging to NSD protein family, functions a...
Autores principales: | Han, Xu, Piao, Lianhua, Yuan, Xiaofeng, Wang, Luhui, Liu, Zhiwei, He, Xiaozhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818196/ https://www.ncbi.nlm.nih.gov/pubmed/31692936 http://dx.doi.org/10.7150/ijms.36128 |
Ejemplares similares
-
The role of histone lysine methyltransferase NSD3 in cancer
por: Han, Xu, et al.
Publicado: (2018) -
NSD2 Promotes Renal Cancer Progression Through Stimulating Akt/Erk Signaling
por: Han, Xu, et al.
Publicado: (2020) -
Erythrocyte membrane protein band 4.1-like 3 inhibits osteosarcoma cell invasion through regulation of Snai1-induced epithelial-to-mesenchymal transition
por: Yuan, Xiaofeng, et al.
Publicado: (2020) -
Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis
por: Liu, Zhiwei, et al.
Publicado: (2017) -
Paxillin knockdown suppresses metastasis and epithelial-mesenchymal transition in colorectal cancer via the ERK signalling pathway
por: Wen, Long, et al.
Publicado: (2020)